Jamin Steffen

Jamin Steffen joined RBC in 2022 and leads a team that performs target-specific assays to support customer projects. He received his PhD in Pharmaceutical Sciences from the University of Arizona, and post-doctoral training as a Ruth L. Kirschstein NRSA fellow from Thomas Jefferson University, studying structural and molecular effects of PARP inhibitors. Jamin has also worked with biotech start-up companies leading various cancer-related research projects.